Porosome Therapeutics, Inc.

BOSTON, MA · Founded 2021 · Biotech · Private

Porosome-based drug delivery platform targeting intracellular transport mechanisms

Claim this profile

Follows are private to you and power your alerts

Updated · porosome.com

Sector
Biotech
Headquarters
BOSTON, MA
Founded
2021
Latest Form D
$1.5M, Sep 2023
Total capital
$1.8M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$1.8M
2 Form D · last Sep 2023
37 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
8 pending

Capital timeline

20222023FEDERAL ↑EQUITY ↓Cumulative $1.8M1st Form D$305K2nd Form D$1.5M
20222023FEDERAL ↑EQUITY ↓Cumulative $1.8M1st Form D$305K2nd Form D$1.5M

Latest events

  • Private capital raisedForm D · SEC · 2nd filing$1.5M
  • Private capital raisedForm D · SEC · 1st filing$305K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings
  • Guillermo MarmolExecutive OfficerNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 8
  • PendingFunctional Porosome ManipulationUSPTOApplication 19265874
  • PendingAerosol And Topical Administration Of A Formulation Containing Cyclodextrin, Quercetin And Zinc, In Combination Or Separately, To Mitigate Infection By Enveloped VirusesUSPTOApplication 18680557
  • PendingFunctional Porosome ManipulationUSPTOApplication 18584830
Show all 8 patent records
  • Functional Porosome ManipulationNov 6, 2025 · Application 19265874Pending
  • Aerosol And Topical Administration Of A Formulation Containing Cyclodextrin, Quercetin And Zinc, In Combination Or Separately, To Mitigate Infection By Enveloped VirusesSep 26, 2024 · Application 18680557Pending
  • Functional Porosome ManipulationSep 26, 2024 · Application 18584830Pending
  • Functional Porosome ManipulationFeb 15, 2024 · Application 18446111Pending
  • Functional Porosome ManipulationApplication 63669321Pending
  • Functional Porosome ManipulationApplication PCTUS2025037151Pending
  • Extracellular Vesicle TreatmentApplication 63606357Pending
  • Correction Of Alzheimer's Disease PathologyApplication 63751184Pending
  • RS BioTherapeutics Inc.Similar federal contract value in Biotech · null in contracts
  • Solaxa Inc.Similar federal contract value in Biotech · null in contracts
  • Rhinal Therapeutics Inc.Similar federal contract value in Biotech · null in contracts
  • CRISPRQC INC.Similar federal contract value in Biotech · null in contracts
  • BioFactura, Inc.Similar federal contract value in Biotech · null in contracts
  • PNP THERAPEUTICS INCSimilar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .